GoldenGolden
ALS Investment Fund

ALS Investment Fund

A venture capital firm in Amsterdam that focuses on supporting and finances biotech companies

ALS Investment Fund is a venture capital firm in Amsterdam that focuses on supporting and finances biotech companies. Founded 2016 in Amsterdam, Noord-Holland, The Netherlands, it invests in series A, series C and venture rounds. Its portfolio companies include Apic Bio, Verge Genomics, Emulate, Orphazyme, and Amylyx Pharmaceutical. As of March 2020, ALS Investment Fund has made five investments. Their most recent investment was on January 7, 2019, when Apic Bio raised $40M. ALS Investment Fund has had one exit, which was Orphazyme. Apic Bio, Inc. is a biotechnology company that advances therapies to treat rare diseases with complex mechanisms.

Timeline

2016
Founded

People

Name
Role
LinkedIn

Felix von Coerper

Managing Partner

Fernando Vieira

Member of Scientific Advisory Board

Melanie Leitner Ph.D

Consultant

Merit Cudkowicz

Member of Scientific Advisory Board

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Emulate

Amylyx Pharmaceutical

Apic Bio

Orphazyme

Verge Genomics

News

Title
Author
Date
Publisher
Description
April 21, 2021
BioSpace
Apic Bio Announces FDA Clearance of IND Application for Lead Gene Therapy Candidate APB-102 for the Treatment of SOD1 ALS - read this article along with other careers information, tips and advice on BioSpace

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.